Intelligent Investor

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Resignation of Director - M Kaye 31 Dec 2021 9:33AM $0.115 $0.010 $0.010 fallen by 91.30%
- Becoming a substantial holder 24 Dec 2021 1:55PM $0.105 $0.010 $0.010 fallen by 90.48%
- Change of Director's Interest Notice AF 22 Dec 2021 4:32PM $0.115 $0.010 $0.010 fallen by 91.30%
- Change of Director's Interest Notice EDS 22 Dec 2021 4:32PM $0.115 $0.010 $0.010 fallen by 91.30%
- Notification regarding unquoted securities - BNO 22 Dec 2021 4:27PM $0.115 $0.010 $0.010 fallen by 91.30%
- Change in substantial holding 22 Dec 2021 8:59AM $0.120 $0.010 $0.010 fallen by 91.67%
- Bionomics Announces Closing of IPO in the US 21 Dec 2021 9:59AM $0.115 $0.010 $0.010 fallen by 91.30%
- Cleansing Notice 20 Dec 2021 11:01AM $0.125 $0.010 $0.010 fallen by 92%
- Application for quotation of securities - BNO 17 Dec 2021 5:59PM $0.135 $0.010 $0.010 fallen by 92.59%
- Proposed issue of securities - BNO 16 Dec 2021 7:35PM $0.115 $0.010 $0.010 fallen by 91.30%
- Bionomics Announces Pricing of IPO in the US 16 Dec 2021 7:35PM $0.115 $0.010 $0.010 fallen by 91.30%
- Trading Halt 16 Dec 2021 10:20AM $0.115 $0.010 $0.010 fallen by 91.30%
- Pause in Trading 16 Dec 2021 9:55AM $0.115 $0.010 $0.010 fallen by 91.30%
- Notification of cessation of securities - BNO 14 Dec 2021 5:18PM $0.120 $0.010 $0.010 fallen by 91.67%
- Bionomics Announces Launch of Proposed IPO in the US 14 Dec 2021 8:16AM $0.120 $0.010 $0.010 fallen by 91.67%
- 2021 New Constitution 2 Dec 2021 12:34PM $0.125 $0.010 $0.010 fallen by 92%
- 2021 AGM Results of Meeting 2 Dec 2021 12:16PM $0.125 $0.010 $0.010 fallen by 92%
- 2021 AGM Executive Chairman's Presentation 2 Dec 2021 9:12AM $0.125 $0.010 $0.010 fallen by 92%
- Fast Track Designation for BNC210 in Social Anxiety Disorder 1 Dec 2021 10:11AM $0.125 $0.010 $0.010 fallen by 92%
- Notification of cessation of securities - BNO 30 Nov 2021 1:34PM $0.120 $0.010 $0.010 fallen by 91.67%
- BNO Files Registration Statement for Proposed IPO in the US 23 Nov 2021 10:49AM $0.105 $0.010 $0.010 fallen by 90.48%
- Update on Possible Capital Distribution 19 Nov 2021 9:56AM $0.110 $0.010 $0.010 fallen by 90.91%
- Bionomics Receives ASX Waiver from LR 10.13.5 18 Nov 2021 4:28PM $0.110 $0.010 $0.010 fallen by 90.91%
- Section 708A Notice 11 Nov 2021 5:43PM $0.125 $0.010 $0.010 fallen by 92%
- Application for quotation of securities - BNO 11 Nov 2021 5:01PM $0.125 $0.010 $0.010 fallen by 92%

101 - 125 of 801 results

Page 5 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.